MedinCell to present at the 23rd Annual Needham Virtual Healthcare Conference March 28, 2024 March 28, 2024
Pharmaceutical Industry Veteran Strategist Philippe Guy Becomes Chairman of MedinCell’s Supervisory Board March 13, 2024 March 13, 2024
[Replay] Medincell Presentation at Evercore ISI 2024 Emerging Biotech Conference February 28, 2024 February 28, 2024
Anh Nguyen stepped down from MedinCell Supervisory Board as Member and Chairman Due to Statutory Age Limit February 19, 2024 February 19, 2024
MedinCell to present at the Evercore ISI 2024 Emerging Biotech Conference February 15, 2024 February 15, 2024
MedinCell’s partner Teva provides guidance for UZEDY in 2024 and an update on olanzapine LAI (mdc-TJK) January 31, 2024 January 31, 2024
Teva announces recruitment completion of phase 3 clinical study of mdc-TJK January 9, 2024 January 9, 2024
In Vitro and In Vivo Hydrolytic Degradation Behaviors of a Drug-Delivery System Based on the Blend of PEG and PLA Copolymers November 27, 2023 November 27, 2023
MedinCell applauds Teva and Royalty Pharma collaboration to further accelerate olanzapine LAI program November 13, 2023 November 13, 2023
